Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
4.5M
-
Shares change
-
+3.54M
-
Total reported value, excl. options
-
$346M
-
Value change
-
+$272M
-
Put/Call ratio
-
0.24
-
Number of buys
-
57
-
Number of sells
-
-16
-
Price
-
$76.84
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2022
104 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q2 2022.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.5M shares
.
Largest 10 shareholders include Phoenix Holdings Ltd. (2.2M shares), UBS Group AG (494K shares), GOLDMAN SACHS GROUP INC (360K shares), MORGAN STANLEY (189K shares), Noked Capital LTD (140K shares), Noked Israel Ltd (140K shares), BANK OF AMERICA CORP /DE/ (93.2K shares), ALTFEST L J & CO INC (71.2K shares), ROYAL BANK OF CANADA (59.7K shares), and JANE STREET GROUP, LLC (58.1K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.